Becker, Crowley, Esserman & Heapy Win Grant Through NIH HEAL Initiative
Yale School of Medicine (YSM) faculty William C. Becker, MD, associate professor (general internal medicine); Susan Crowley, MD, FASN, professor of medicine (nephrology); and Alicia Heapy, PhD; associate professor of psychiatry; teamed with Yale School of Public Health’s (YSPH) Denise Esserman, PhD, associate professor of biostatistics, were recently awarded a grant for their project, “Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving Hemodialysis” through The Helping to End Addiction Long-term, or the NIH HEAL Initiative.
FDA OKs Canagliflozin to Curtail Diabetic Kidney Disease
The US Food and Drug Administration (FDA) has approved canagliflozin (Invokana, Janssen) to reduce the risk of end-stage kidney disease, worsening of kidney function, cardiovascular death, and heart failure hospitalization, in adults with type 2 diabetes and diabetic kidney disease.
Yale Investigators Receive NIH HEAL Grants to Study Solutions to the Opioid Crisis
Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.
Living kidney donors face higher risk of hypertension
Compared with non-donors, living kidney donors face a higher risk of developing hypertension, which may have negative effects on their kidney function. The findings, which appear in an upcoming issue of CJASN, indicate the importance of preventing and managing hypertension in individuals who are kidney donors.
For-profit dialysis center patients less likely to receive a transplant, study finds
Patients with renal failure who get dialysis at for-profit dialysis centers are less likely to receive a kidney transplant than patients who get dialysis at nonprofit centers, according to a study published Tuesday in JAMA.
FDA Sunscreen Study Says Little — But Opens Door To More Research
The ingredients in chemical sunscreen enter the bloodstream after just one day of use, according to a new study conducted by the Food and Drug Administration. But that doesn't tell us much. Here & Now's Robin Young checks in with Dr. Perry Wilson (@methodsmanmd), assistant professor of medicine at Yale University, to break down the study results.
Urine Biomarkers Could Improve Diagnosis of Serious Kidney Allergic Reaction
A team led by Johns Hopkins Medicine researchers says it has identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis (AIN), an underdiagnosed but treatable kidney disorder that impairs renal function in the short term and can lead to chronic kidney disease, permanent damage or renal failure if left unchecked.
Fedeles Wins Inaugural Young Investigator Award from PKDF
Sorin Fedeles, PhD, MBA, Blavatnik Fellow and former research faculty in the Section of Nephrology won the 2019 Young Investigator Award from the Polycystic Kidney Disease Foundation (PKDF) for his project studying autosomal dominant polycystic kidney disease (ADPKD) entitled, “Controlling the viability of PKD mutant cells via inactivation of XBP1 as a novel strategy to treat ADPKD.”
Welcome START@Yale MD-PhD Students
Four incoming MD-PhD students are participating in the Summer to Advance Research Training at Yale School of Medicine (START@Yale) program which provides students with a mentored research experience and associated educational activities during the summer before the first year of medical school. Click below to read about why they decided to participate in START!